Decoy Therapeutics Inc. (DCOY) Free cash flow 2016–2021
Decoy Therapeutics Inc. (DCOY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.2MFY2021 · since FY2016: -$32.6M → -$10.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -$10.2M | +1.1% |
| FY2020 | -$10.3M | +10.9% |
| FY2019 | -$11.6M | -377.2% |
| FY2018 | $4.2M | +115.0% |
| FY2017 | -$27.8M | +14.6% |
| FY2016 | -$32.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice